TYMLOS®demonstrated a lower incidence of hip fracture and non-vertebral fracture compared to teriparatide in women with osteoporosis 50 years and older (n=43,352) in this analysis of real-world dat...
Radius is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of osteoporosis, cancer, and endocrine diseases.